Med.xyz Logo
Peptide Intelligence

Taking a peptide? Know what it's doing to your body.

Med.xyz brings your therapies, labs, body composition, nutrition, activity, sleep and symptoms together so you and your healthcare team can make better-informed decisions. We don't sell peptides. We don't tell you which one to take.

Understand your peptide We don't sell or prescribe. Wellness guidance only.
  • Updated after every FDA and HHS action. Last: FDA updates its 'concerns with unapproved GLP-1 drugs' page (Sep 1, 2026).
  • As of September 2026, no wellness peptide is FDA-approved and none is legally compoundable yet. The July 2026 committee votes were advisory.
  • Every entry shows approval status, compounding status, evidence grade, risks, what to monitor and questions for your clinician.

Free · searches our registry

Before you take it, understand it.

Approval status, compounding status, evidence grade, known risks, what to monitor, and questions for your clinician.

Try one of the six from the July 2026 committee vote: BPC-157, TB-500, KPV, MOTS-c, Semax, epitalon.

6

Peptides PCAC recommended, Jul 2026 (advisory)

0

Wellness peptides FDA-approved

12–24 mo

Typical rulemaking timeline

$0

For status, evidence and monitoring lists

Discover by status

Grouped by regulatory tier, then alphabetical. No ranking by benefit.

FDA-approved products

Liraglutide

Saxenda · Victoza

FDA-approvedApproved product · compounded versions are unapprovedEvidence A · Human randomized trialsStatus as of 2026-09-02

PT-141

Bremelanotide · Vyleesi

FDA-approvedApproved productEvidence A · Human randomized trialsStatus as of 2026-09-02

Semaglutide

Ozempic · Wegovy

FDA-approvedApproved product · compounded versions are unapprovedEvidence A · Human randomized trialsStatus as of 2026-09-02

Tesamorelin

Egrifta

FDA-approvedApproved productEvidence A · Human randomized trialsStatus as of 2026-09-02

Testosterone

TRT · Testosterone cypionate

FDA-approvedApproved productEvidence A · Human randomized trialsStatus as of 2026-09-02

Tirzepatide

Mounjaro · Zepbound

FDA-approvedApproved product · compounded versions are unapprovedEvidence A · Human randomized trialsStatus as of 2026-09-02

Investigational

Enclomiphene

Status under review
Investigational (in trials)Compounding status varies by productEvidence B · Small or uncontrolled human studiesStatus as of 2026-09-02

Retatrutide

LY3437943

Investigational (in trials)Sold as research-use-only · unapproved drugEvidence B · Small or uncontrolled human studiesStatus as of 2026-09-02

Not approved · under FDA review for compounding

BPC-157

Body Protection Compound 157 · Pentadecapeptide BPC 157

Not FDA-approvedPCAC-recommended (Jul 2026) · rulemaking pendingEvidence C · Animal or in-vitro onlyStatus as of 2026-09-02

Epitalon

Epithalon · Epithalamin

Not FDA-approvedPCAC-recommended (Jul 2026) · rulemaking pendingEvidence C · Animal or in-vitro onlyStatus as of 2026-09-02

KPV

Lys-Pro-Val

Not FDA-approvedPCAC-recommended (Jul 2026) · rulemaking pendingEvidence C · Animal or in-vitro onlyStatus as of 2026-09-02

MOTS-c

Not FDA-approvedPCAC-recommended (Jul 2026) · rulemaking pendingEvidence C · Animal or in-vitro onlyStatus as of 2026-09-02

Semax

Not FDA-approvedPCAC-recommended (Jul 2026) · rulemaking pendingEvidence B · Small or uncontrolled human studiesStatus as of 2026-09-02

TB-500

Thymosin beta-4 fragment · Tβ4

Not FDA-approvedPCAC-recommended (Jul 2026) · rulemaking pendingEvidence C · Animal or in-vitro onlyStatus as of 2026-09-02

Not approved · research-use-only

Sold as research-use-only: unapproved drugs with no quality assurance. FDA has issued warnings about products in this tier.

AOD-9604

Status under review
Not FDA-approvedFDA Category 2 (may not be compounded)Evidence B · Small or uncontrolled human studiesStatus as of 2026-09-02

CJC-1295

CJC-1295 DAC · Modified GRF (1-29)

Status under review
Not FDA-approvedFDA Category 2 (may not be compounded)Evidence B · Small or uncontrolled human studiesStatus as of 2026-09-02

Ipamorelin

Status under review
Not FDA-approvedFDA Category 2 (may not be compounded)Evidence B · Small or uncontrolled human studiesStatus as of 2026-09-02

Melanotan II

MT-2

Status under review
Not FDA-approvedSold as research-use-only · unapproved drugEvidence C · Animal or in-vitro onlyStatus as of 2026-09-02

NAD+

Nicotinamide adenine dinucleotide

Status under review
Not FDA-approvedCompounding status varies by productEvidence C · Animal or in-vitro onlyStatus as of 2026-09-02

What the Program adds

Prepare checklist

Things people often measure before starting a compound (CMP, CBC, lipids, A1c, hormones, blood pressure, body composition, sleep baseline), framed for a conversation with your clinician.

Therapy dashboard

Week N, dose log, product type and vendor, side effects, and your labs, weight, lean mass, strength, sleep and heart-rate variability overlaid since the start date.

Safety overlay

Liver enzymes, lipids, hematocrit on TRT, IGF-1 on secretagogues, glucose on metabolic peptides, plotted on the dose timeline with escalation to a clinician packet when a trend is worth a look.

Questions, answered

Do you sell peptides or tell me which one to take?

Neither. Med.xyz never sells a compound and never ranks compounds by predicted benefit. The Discover view is ordered by regulatory status, then alphabetically, so you always see what is approved before what is not.

What does "PCAC recommended" mean for BPC-157?

On July 23–24, 2026 the FDA's Pharmacy Compounding Advisory Committee voted to recommend adding BPC-157 and five other peptides to the list of substances 503A pharmacies may compound. The vote is advisory. Until FDA completes rulemaking, which typically takes 12–24 months, nothing has changed legally and research-use-only products remain unapproved drugs.

What is "research use only"?

A label sellers use to ship a substance that is not approved for human use. In FDA's view it is an unapproved drug. There is no required testing of identity, purity, sterility or concentration, which is why contamination and mislabeling are the main practical risks.

How are evidence grades assigned?

A means human randomized controlled trials. B means small or uncontrolled human studies. C means animal or in-vitro data only. D means none or anecdotal. Every entry cites its sources and carries a status-as-of date, and entries under review show that label instead of publishing.

What does the Program add on top of the checker?

A therapy record with product type and source, a dashboard that overlays your labs, body composition, sleep and strength on the dose timeline, monitoring suggestions per compound, and a clinician packet with the questions worth asking.

The peptide isn't the plan. What happens to your body after you start is.

Understand your peptide

Med.xyz is a general-wellness product. It does not diagnose, treat or prescribe. Statistics on this page link to their sources; see the disclaimer.